Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll FOXP3 as an X-linked tumor suppressor Wang L; Liu R; Ribick M; Zheng P; Liu YDiscov Med 2010[Oct]; 10 (53): 322-8The FOXP3 gene was initially identified because its mutation caused lethal autoimmune diseases in mice and humans. Mice with heterozygous mutations of FoxP3 (mouse version of the FOXP3 gene) succumb to mammary tumors spontaneously, while those with prostate-specific deletions develop prostate intraepithelial neoplasia. Somatic mutations, deletion, and epigenetic inactivation of FOXP3 are widespread among human breast and prostate cancers. Unlike autosomal tumor suppressor genes that are usually inactivated by mutations in both alleles, X-linked FOXP3 mutations in cancer samples are usually heterozygous, with the wildtype allele selectively inactivated in cancer. This skewed X-inactivation suggests a new approach to reactivation of FOXP3 for cancer therapy.|Animals[MESH]|Breast Neoplasms/genetics/therapy[MESH]|Carcinoma/genetics/therapy[MESH]|Female[MESH]|Forkhead Transcription Factors/genetics/metabolism/*physiology[MESH]|Gene Silencing/physiology[MESH]|Humans[MESH]|Male[MESH]|Mice[MESH]|Models, Biological[MESH]|Prostatic Neoplasms/genetics/therapy[MESH]|Tumor Suppressor Proteins/genetics/metabolism/*physiology[MESH] |